Fig. 2From: Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PETCompetition experiments using [125I]I-(Leu8, d-Trp22, Tyr25)-somatostatin 28 as radioligand with increasing concentrations of SiTATE on human sst1-5 membrane preparationsBack to article page